Skip to main content

Trinity College Dublin, The University of Dublin

Menu Search


Trinity College Dublin By using this website you consent to the use of cookies in accordance with the Trinity cookie policy. For more information on cookies see our cookie policy.

      
Profile Photo

Dr. Mary Teeling

Adjunct Assistant Professor (p/t) (Pharmacology & Therapeutics)

 teelinm@tcd.ie

 


Biography

I am a specialist pharmaceutical physician with extensive experience in the areas of pharmacology and pharmaceutical medicine. In addition to my role as Assistant Professor, in the School of Medicine, Trinity College Dublin, I also work in the National Medicines Information Centre (NMIC) as a part-time medical advisor. I worked in the national regulatory authority (Irish Medicines Board) for 12 years and served as its medical director from 1995-2000. I was a member of the European scientific committee (Committee for Human Medicinal Products) from 1994-2000 and was appointed to the role of vice-chairman in 1998 until 2000. In my role as medical advisor in the NMIC, I am the co-author of the NMIC publications Therapeutics Today and NMIC Bulletin, which provide updates on therapeutic topics to primary care physicians and other healthcare professionals. I was part of the education team that developed the higher specialist training (HST) programme in Pharmaceutical Medicine, in conjunction with the Royal College of Physicians in Ireland (RCPI). I am currently the National Specialty Director for Pharmaceutical Medicine and a member of the Irish Committee for Higher Medical Training (ICHMT) in RCPI.

Research Tags

  MEDICAL EDUCATION   MEDICATION USE   Medicines

Representations

Details Date
National Specialty Director, Pharmaceutical Medicine, Royal College of Physicians of Ireland. 2013-
Vice chairman of the Committee for Proprietary Medicinal Products (CPMP, European Medicines Agency 1998-2000
EU member of the Steering Committee on International Conference on Harmonisation (ICH) 1999-2000
Former chairman of the Scientific Advice Working Party, European Medicines Agency 1998-2000
Former chairman of the CPMP ad hoc committee on anti-cancer agents 1997-2000

Languages

Language Skill Reading Skill Writing Skill Speaking
English Fluent Fluent Fluent

Memberships

Membership of Professional Institutions, Associations, Societies

Details Date From Date To
Royal Academy of Medicine in Ireland (fellow)
International Society of Pharmacoepidemiology
Association of Pharmaceutical Physicians of Ireland (APPI)
Royal College of Physicians of Ireland (Fellow)
Teeling M, MacAvin M, Bennett K, Impact of safety warnings on domperidone prescribing in Ireland, Irish Journal of Medical Science, 2017, p5 , Notes: [doi: 10.1007/s11845-017-1657-1], Journal Article, PUBLISHED  URL  URL  URL
Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, Wallace E, Cahir C, Williams D, Teeling M, Hughes CM., Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria., European Journal of Clinical Pharmacology, 72, (5), 2016, p583 - 591, Journal Article, PUBLISHED
O'Shea MP, Teeling M, Bennett K., Comorbidity, health-related quality of life and self-care in type 2 diabetes: a cross-sectional study in an outpatient population., Irish Journal of Medical Science, 184, (3), 2015, p623 - 630, Journal Article, PUBLISHED
O'Shea MP, Teeling M, Bennett K., Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland, Irish Journal of Medical Science, 184, (2), 2015, p403 - 410, Journal Article, PUBLISHED
Cooper JA, Ryan C, Smith SM, Wallace E, Bennett K, Cahir C, Williams D, Teeling M, Fahey T, Hughes CM; (The PROMPT Steering Group) , The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria., BMC Health Services Research, 14, 2014, p13 , Journal Article, PUBLISHED
O'Shea MP, Teeling M, Bennett K., An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents., Pharmacoepidemiology and Drug Safety, 12, 2013, p1336 - 1344, Journal Article, PUBLISHED
O'Shea M, Teeling M, Bennett K, The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: A retrospective cross-sectional study using a national pharmacy claims database., BMC health services research, 13, 2013, p23 , Journal Article, PUBLISHED  TARA - Full Text  DOI
Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K, , Potentially inappropriate prescribing and cost outcomes for older people: a national population study, British Journal of Clinical Pharmacology, 69, 2010, p542 - 552, Journal Article, PUBLISHED
M. Teeling, H. O'Connor, J. Feely, K. Bennett, What therapies have replaced rofecoxib in Ireland ?, British Journal of Clinical Pharmacology, 64, (4), 2007, p536 - 541, Journal Article, PUBLISHED
M. Savage, M. Teeling, K. Bennett, J. Feely, Adherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillation, Irish Journal of Medical Science, 175, (2), 2006, p46 - 49, Journal Article, PUBLISHED
  

Page 1 of 5
Pharmacovigilance and Risk Management in, editor(s)A C Cartwright, B R Matthews , International Pharmaceutical Product Registration, , United Kingdom, Informa Healthcare, 2009, [Informa Healthcare], Book Chapter, PUBLISHED
M. Teeling, J. Feely, Prevention of NSAID side effects, Clinical Focus (Forum), 5, (4), 2005, p4 - 6, Journal Article, PUBLISHED
M. Teeling, K. Bennett, J. Feely, Have COX 2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs ?, British Journal of Clinical Pharmacology, 55, 2004, 419, Meeting Abstract, PUBLISHED
Teeling M., "Use of Lofexidine and Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003, Report, PUBLISHED
Teeling M., "Use of Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003, Report, PUBLISHED
Teeling M., "Use of Buprenorphine as an intervention in the treatment of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2002, Report, PUBLISHED
Teeling M., Licensing of Vaccines, Forum, 17, (7), 2000, p39 - 41, Journal Article, PUBLISHED
Teeling M, The European Regulatory Perspective: Scientific Advice, Int J. Pharm Med, 13, 1999, p92 - 92, Journal Article, PUBLISHED
Teeling M, Immunisation: New developments in vaccines, Modern Medicine, 27, (10), 1997, p67 - 68, Journal Article, PUBLISHED
Teeling M., Initial Experiences with the New European Regulatory Procedures, J. Eur Soc Reg Affairs, 3, (3), 1996, p53 - 54, Journal Article, PUBLISHED

  

Awards and Honours

Award Date
1999 Outstanding Service Award - Drug Information Association (DIA). 1999

Research Interests

Description Of Research Interests

. Clinical Pharmacology . Pharmaceutical Medicine . Clinical Oncology . Pharmacoepidemiology